Screening of antiangiogenie activity of some tropical plants by rat aorta ring assay

International Journal of Pharmacology

Volumn 5, Issue 6, 2009, Pages 370-376

  Aisha, A F A ^a   Abu Salah, K M ^b   Darwis, Y ^a   Abdul Majid, A M S ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Angiogenesis; Rat aorta ring assay; Tropical plants

Indexed keywords

CASSIA FISTULA EXTRACT; DELONIX REGIA EXTRACT; GARCINIA MANGOSTANA EXTRACT; PARKIA SPECIOSA EXTRACT; PUNICA GRANATUM EXTRACT; SANDORICUM KOETJAPE EXTRACT; SYZYGIUM COMPANULATUAN EXTRACT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; BARK; CANCER CELL; CASSIA FISTULA; CELL STRAIN HCT116; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DELONIX REGIA; DRUG PURIFICATION; DRUG SCREENING; ENDOTHELIUM CELL; FLOWER; FRUIT; GARCINIA MANGOSTANA; MALE; NONHUMAN; PARKIA SPECIOSA; PERICARP; PLANT; PLANT LEAF; PLANT SEED; PLANT STEM; POMEGRANATE; RAT; SANDORICUM KOETJAPE; SYZYGIUM COMPANULATUAN; UMBILICAL VEIN; VASCULAR RING;

EID: 73449140438     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2009.370.376     Document Type: Article

References (19)

1. Aisha, A.F.A., H.B. Sahib, K.M. Abu-Salah, Y. Darwis and A.M.S. Abdul Majid, 2009. Cytotoxic and antiangiogenic properties of the stem bark extract of Sandoricum koetjape Int. J. Cancer Res., 5: 105-114.
2. Bosari, S., A.K. Lee, R.A. DeLellis, B.D. Wiley, G.J. Heatley and M.L. Silverman, 1992. Micro vessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol., 23: 755-761.
3. Brown, K.J., S.F. Maynes, A. Bezos, D.J. Maguire, M.D. Ford and C.R. Parish, 1996. A novel in vitro assay for human angiogenesis. Lab. Invest., 75: 539-555.
4. Eatock, M.M., A. Schatzlein and S.B. Kaye, 2000. Tumor vasculature as a target for anticancer therapy. Cancer Treat Rev., 26: 191-204.
5. Folkman, J., 1990. What is the evidence t hat tumors are angiogenesis dependent? J. Natl. Cancer. Inst., 82: 4-6.
6. Folkman, J., 1995. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat. Med., 1: 27-31.
7. Giordano, F.J. and R.S. Johnson, 2001. Angiogenesis: The role of the microenvironment in flipping the switch. Curr. Opin Genet. Dev., 11: 35-40.
8. Hurwitz, H., L. Fehrenbacher, W. Novotny, T. Cartwright and J. Hainsworth et al., 2004. Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer. N. Engl. J. Med., 350: 2335-2342.
9. Matsumoto, K., Y. Akao, E. Kobayashi, K. Ohguchi and T. Ito et al., 2003. Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines. J. Nat. Prod., 66: 1124-1127.
10. McMahon, G.A., E. Petitclerc, S. Stefansson, L. Smith and M.K. Wong et al., 2001. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem., 276: 33964-33968.
11. Mosmann, T., 1983. Rapid calorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. J. Immunol. Meth., 65: 55-63.
12. Nicosia, R.F. and A. Ottinetti, 1990. Crowth of micro vessels in serum free matrix culture of rat aorta: A quantitative assav of angiogenesis in vitro. Lab. Invest., 63: 115-122.
13. Nicosia, R.F., Y.L. Lin, D. Hazelton and X. Qian, 1997. Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. Am. J. Pathol., 151: 1379-1386.
14. Passaniti, A., R.M. Taylor, R. Pili, Y. Guo and P.V. Long et al., 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor. Lab. Invest., 67: 519-528.
15. Pfeffer, U., N. Ferrari, M. Morini, R. Benelli, D.M. Noonan and A. Albini, 2003. Antiangiogenic activity of chemotherapeutic drugs. Int. J. Biol. Makers, 18: 70-74.
16. Robert, A., L. Rachel, S. Brenda, K. Louis and A. Nasim, 2003. Angiogenesis assays: A critical overview. Clin. Chem., 49: 32-40.
17. Scappaticci, F.A., 2003. The therapeutic potential of novel antiangiogenic therapies. Expert Opin. Invest. Drugs, 12: 923-932.
18. Toi, M., H. Bando, C. Ramachandran, S.J. Melnick and A. Imai et al., 2003. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis, 6: 121-128.
19. Udagawa, T., A. Fernandez, E.G. Achilles, J. Kolkman and K.J. Damato, 2002. Persistence of microscopic human cancers in mice: Alterations in the angiogenic balance accompanies loss of tumor dormancy. Faseb. J., 16: 1361-1370.